Fluoxetine

Consider a dose increase after several weeks if insufficient clinical improvement is observed. Administer doses above 20 mg/day once daily in the morning or twice daily (i.e., morning and noon). In controlled trials used to support the efficacy of fluoxetine, patients were administered morning doses ranging from 20 to 80 mg/day.

Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.

When using fluoxetine and olanzapine in combination, also refer to the Contraindications section of the package insert for Symbyax., Serotonin Syndrome and MAOIs: Do not use MAOIs intended to treat psychiatric disorders with fluoxetine or within 5 weeks of stopping treatment with fluoxetine. Do not use fluoxetine capsules within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start fluoxetine in a patient who is being treated with linezolid or intravenous methylene blue, Pimozide: Do not use.

Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.

When using fluoxetine and olanzapine in combination, also refer to the Warnings and Precautions section of the package insert for Symbyax., Suicidal Thoughts and Behaviors in Children, Adolescents, and Young Adults: Monitor for clinical worsening and suicidal thinking and behavior, Serotonin Syndrome: Serotonin syndrome has been reported with SSRIs and SNRIs, including fluoxetine, both when taken alone, but especially when co-administered with other serotonergic agents. If such symptoms occur, discontinue fluoxetine and serotonergic agents and initiate supportive treatment.

Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.

The following adverse reactions are discussed in more detail in other sections of the labeling: Suicidal Thoughts and Behaviors in Children, Adolescents, and Young Adults, Serotonin Syndrome, Allergic Reactions and Rash, Screening Patients for Bipolar Disorder and Monitoring for Mania/Hypomania, Seizures, Altered Appetite and Weight, Increased Risk of Bleeding, Angle-Closure Glaucoma, Hyponatremia, Anxiety and Insomnia, QT…

Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.

317 products from 200 makers in the NepalDoc medicine catalog use this generic:

Showing 30 of 317 catalog products. Search the full catalog in the app.

Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.

Protect from light and preserve in tight containers. Store at 20° to 25°C (68° to 77°F);

Storage information from the U.S. FDA-approved label.